Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance

NCT07131631 is registered in ClinicalTrials.gov with Minneapolis Heart Institute Foundation as lead sponsor.

NCT NCT07131631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07131631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
Lead sponsor
Minneapolis Heart Institute Foundation
Phase
Observational
Overall status
Recruiting
Start date
March 3, 2022
Completion date
July 31, 2027
Enrollment
125 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

functional mitral regurgitation, heart failure and reduced ejection fraction